1. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma
   Kyoko Oura et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
2. Research advances in branched-chain amino acid metabolism in tumors
   Zheng Li et al, 2024, Molecular and Cellular Biochemistry CrossRef
3. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma
   Michele Barone et al, 2019, World Journal of Gastroenterology CrossRef
4. Adjuvant Therapy for Hepatocellular Carcinoma after Curative Treatment
   Wen-Juei Jeng et al, 2014, Digestive Diseases CrossRef
5. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
   Imogen M. Roth et al, 2019, Frontiers in Oncology CrossRef
6. Systematic review with meta‐analysis: Branched‐chain amino acid supplementation in liver disease
   Anne M. van Dijk et al, 2023, European Journal of Clinical Investigation CrossRef
7. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
   Fereshteh Asgharzadeh et al, 2020, Current Pharmaceutical Design CrossRef
8. Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study
   Antonio Facciorusso et al, 2020, Biomedicines CrossRef
9. Local ablative treatments for hepatocellular carcinoma: An updated review
   Antonio Facciorusso et al, 2016, World Journal of Gastrointestinal Pharmacology and Therapeutics CrossRef